Salud

Pfizer probará una tercera dosis contra covid-19 en su ensayo con niños de 2 a 5 años

Dos dosis no levantaron la cantidad de protección esperada; tercer inyección se colocaría dos meses después de la primera

A vial of the Biontech-Pfizer vaccine Comirnaty in the pediatric dosage (L) is on display next to a vial in the adult dosage in a pediatrician's office in Berlin on December 14, 2021, at the start of COVID-19 vaccination campaign for children under 12 years in Germany. (Photo by Tobias SCHWARZ / AFP)
A vial of the Biontech-Pfizer vaccine Comirnaty in the pediatric dosage (L) is on display next to a vial in the adult dosage in a pediatrician's office in Berlin on December 14, 2021, at the start of COVID-19 vaccination campaign for children under 12 years in Germany. (Photo by Tobias SCHWARZ / AFP) TOBIAS SCHWARZ
‌
‌

‌

‌
‌

‌

‌